Esophageal Cancer in Northeastern Iran | MicrobiomeTrials← Back to trialsNCT00450788
Esophageal Cancer in Northeastern Iran
CompletedOBSERVATIONAL
Trial Details
Enrollment target: 50,045 participants Locations- Digestive Disease Research Institute, Tehran, Iran
Other microbiome trials you might be interested in
Esophageal Squamous Cell CarcinomaImmunotherapyBiomarkers
To evaluate the efficacy and safety of adebrelimab with or without induction chemotherapy followed by concurrent chemora…
Fuzhou, ChinaEst. completion Dec 2027
Breast NeoplasmsColorectal NeoplasmsProstate NeoplasmEndometrial NeoplasmsNeoplasm MetastasisStomach Neoplasms
Esophageal Neoplasms
The main purpose of this study is to evaluate safety, tolerability, and efficacy of LY4257496 alone and as part of relev…
Duarte, United StatesEst. completion Apr 2030
Advanced Esophageal Squamous Cell CarcinomaMetastatic Esophageal Squamous Cell Carcinoma
The purpose of this study is to evaluate the pharmacokinetic (PK) profile, safety, and efficacy of tislelizumab administ…
Yokohama, JapanEst. completion Feb 28, 2028